Where does Receptos LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Receptos LLC ranks #15,573 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Receptos LLC hold?

Receptos LLC holds 19 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is Receptos LLC's Innovation Score?

Receptos LLC has an Innovation Score of 36.4 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Receptos LLC focus on?

Receptos LLC's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 19 patents, ranking #1,031 of 6,058 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Receptos LLC's patent grant rate increasing or decreasing?

Receptos LLC's recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Receptos LLC's patents?

Receptos LLC's patents average 17.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Receptos LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Receptos LLC

USPTO PatentsView assignee record - 19 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Receptos ranks #15,573 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 9 technology areas.

#15,573
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.4/100): 17.8
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15573 · US Corporation #15,573 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 19 grants
MID-PACK #15,573/49,997
PHOTO-FINISH Rapyuta Robotics
CPC-NARROW A61P · 9 areas
INNOV-THIN 36.4/100
CLAIMS-RICH 17.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Rapyuta Robotics Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Receptos’s 36.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (28%) Velocity 4.8 pts (13%) Breadth 10.6 pts (29%) Claim depth 10.7 pts (29%)

Qualcomm Incorporated · highest

85
Receptos · this assignee

36
3D Lighting… · lowest

7

What this shows Receptos's Innovation Score is 36.4/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Receptos?

Each dot is one of Receptos’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Receptos’s own 17.8 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Receptos vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Receptos's grants concentrate

Receptos LLC is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (7 grants) versus a trough of 1 in 2015. By volume, Receptos sits between Rapyuta Robotics Co., Ltd. and RevoLabs, Inc.

Receptos's three-year grant acceleration

Receptos LLC shows 5 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Rapyuta Robotics

19
Razer Auto

19
Realtime Data

19
Recargo

19
Red Leaf Resources

19
Rehco

19
Reveal Energy Ser…

19
Revolabs

19
Receptos ◀

19

What this shows Receptos holds 19 patents at rank #15,571, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Receptos

By rank, the assignees closest to #15,571 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Receptos's primary technology class.

Receptos's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Receptos LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.3%
2016	3	15.8%
2021	7	36.8%
2022	2	10.5%
2023	1	5.3%
2024	2	10.5%
2025partial year	3	15.8%

Which technologies does Receptos LLC patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 19

C07D - Heterocyclic Compounds 16

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 7

C07K - Peptides 2

C08B - POLYSACCHARIDES; Derivatives Thereof 1

C08L - Compositions OF Macromolecular Compounds 1

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

C07C - Acyclic OR Carbocyclic Compounds 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Receptos LLC's patent record in context - here's where to go next.

Receptos LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #15,573 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Receptos LLC against Rapyuta Robotics Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.